At the time of writing, Vor Biopharma Inc [VOR] stock is trading at $1.53, up 16.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The VOR shares have gain 11.68% over the last week, with a monthly amount glided 72.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on July 26, 2022, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. Previously, Goldman started tracking the stock with Neutral rating on April 27, 2022, and set its price target to $6. On December 17, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $38 on December 03, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 02, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2021, and assigned it a price target of $40. In a note dated March 25, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $60 on this stock.
For the past year, the stock price of Vor Biopharma Inc fluctuated between $0.63 and $2.50. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $1.53 at the most recent close of the market. An investor can expect a potential return of 292.16% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at -9.65%, Pretax Profit Margin comes in at -9.2%, and Net Profit Margin reading is -9.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -1.01 and Total Capital is -1.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3200 points at the first support level, and at 1.1100 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6400, and for the 2nd resistance point, it is at 1.7500.
Ratios To Look Out For
It is important to note that Vor Biopharma Inc [NASDAQ:VOR] has a current ratio of 4.69. On the other hand, the Quick Ratio is 4.69, and the Cash Ratio is 3.68.
Transactions by insiders
Recent insider trading involved Attar Eyal C., CHIEF MEDICAL OFFICER, that happened on Dec 27 ’24 when 10334.0 shares were sold. Officer, EYAL ATTAR completed a deal on Dec 27 ’24 to buy 10334.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Attar Eyal C. sold 14645.0 shares on Jun 03 ’24.
